|
|
||||||||

1 Division of Molecular Pharmacology and Pharmacogenomics, Department of Biochemistry and Molecular Biology, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan
2 Department of Pharmacology, China Medical University, 92 North 2nd Road, Heping District, Shenyang 110001, China
3 Laboratory of Molecular Pharmacogenomics, School of Pharmaceutical Sciences, Kinki University, Kowakae 3-4-1, Higashi-Osaka 577-8502, Japan
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
The mammalian genome contains a single gene encoding HMGR that has a COOH-terminal catalytic region connected by a linker to an NH2-terminal hydrophobic region that is responsible for endoplasmic reticulum (ER) localization (Liscum et al. 1985; Luskey & Stevens 1985) and is required for regulated ER degradation of the native enzyme (Nakanishi et al. 1988). In budding yeast Saccharomyces cerevisiae, two structural genes (HMG1 and HMG2) encode two isozymes of HMGR, Hmg1p and Hmg2p, respectively (Basson et al. 1986) that are integral ER membrane proteins containing a COOH-terminal catalytic domain and an NH2-terminal hydrophobic region (Basson et al. 1988; Wright et al. 1988). Hmg1p contributes most of the activity found in wild-type cells, and a single deletion mutant of HMG1 or HMG2 has only a subtle growth defect, but cells containing hmgl hmg2 double mutation are inviable (Basson et al. 1986, 1987) and can be rescued by the expression of the mammalian HMGR gene (Basson et al. 1988), suggesting a functional conservation. Hmg1p is quite stable, whereas Hmg2p is rapidly degraded in a regulated manner similar to that in the mammalian HMGR (Hampton & Rine 1994). Overexpression of Hmg1p causes the proliferation of the ER membrane, resulting in the stacked perinuclear structures named "karmellae" (Wright et al. 1988).
In fission yeast Schizosaccharomyces pombe, there is a single gene, hmg1+, that encodes HMGR and was isolated on the basis of its ability to confer resistance to lovastatin, a competitive inhibitor of HMGR. Gene knockout analysis showed that hmg1+ is an essential gene (Lum et al. 1996). The expression in fission yeast of increased levels of the S. cerevisiae HMGR isozyme encoded by HMG1 induced "karmellae" formation (Lum & Wright 1995). The regulatory mechanism of a family of ER membrane bound transcription factors called sterol regulatory element binding proteins has been studied extensively (Hughes et al. 2005; Burg et al. 2008). However, limited information is available regarding the phenotypes caused by mutations in the hmg1+ gene.
In this study, we report the isolation of an allele of the hmg1+ gene, hmg1-1/its12, as a mutant that showed sensitivities to high temperature and to FK506, a calcineurin inhibitor. In the hmg1-1 mutant, tryptophan at the 234th position was mutated to an opal termination codon that was read through to result in the mistranslated full-length protein. To our knowledge, this is the first demonstration of clear phenotypes arising from a nonsense mutation of an essential gene in fission yeast.
| Results |
|---|
|
|
|---|
We isolated a new its mutant (its for immunosuppressant- and temperature-sensitive; Zhang et al. 2000) that was sensitive to temperature and to the calcineurin inhibitor FK506, and named it its12 mutant. As shown in Fig. 1A, the its12 mutant grew slightly more slowly than the wild-type cells at 27 °C. The its12 mutant cells failed to grow at 36 °C and they grew poorly or barely grew on YPD plate containing FK506 at 27 °C, whereas wild-type cells grew normally (Fig. 1A). Tetrad analysis was performed by crossing the its12 mutant with calcineurin deletion (
ppb1) strain. Results showed that no double mutant was obtained, indicating that its12 mutation and calcineurin deletion are synthetically lethal (data not shown).
|
The mutated gene in its12 mutant was cloned by complementation of the temperature-sensitive growth (Fig. 1A). Nucleotide sequencing of the cloned DNA fragment revealed that in its12 mutant, the mutated gene with the systematic identification SPCC162.09c is hmg1+ that encodes HMGR consisting of a 1053-amino acid sequence. To investigate the genetic relationship between the mutated gene and the hmg1+ gene, linkage analysis was performed as follows. The hmg1+ gene was subcloned into the pUC-derived plasmid containing budding yeast LEU2 gene. Using this construct, the LEU2 gene was integrated by homologous recombination into the hmg1+ gene locus of the genome of KP207 (Table 1). The integrant was mated with its12 strain, and the resultant diploid was sporulated. When the tetrads were dissected, only parental ditype tetrads were found, indicating that the mutated gene was tightly linked to the hmg1+ gene locus (data not shown). Therefore we renamed the its12 mutant as hmg1-1 mutant.
|
The hmg1-1 mutant cells showed hypersensitivity to pravastatin
As the results described above suggest that the sterol biosynthesis is defective in the hmg1-1 mutant cells, we then examined the effect of pravastatin, a competitive inhibitor of HMGR. As shown in Fig. 1C, the growth of the hmg1-1 mutant was significantly inhibited by pravastatin as compared with that of wild-type cells. Studies have reported that the budding yeast cells containing a mutant allele of either HMG1 or HMG2 are viable but are more sensitive to compactin, an inhibitor of HMGR, as compared with that of the wild-type cells. The above results suggest that the hmg1-1 cells contained less HMGR activity as compared with that of wild-type cells.
Intracellular localization of Hmg1-GFP
To examine the intracellular localization of Hmg1 in wild-type cells, the gene was tagged at its C terminus with GFP carrying the S65T mutation. The construct was functional as its thiamine-repressed expression complemented the phenotypes of the hmg1-1 mutant (Fig. 2A). Chromosome-borne Hmg1-GFP was primarily localized in the nuclear envelope and was also observed in the peripheral ER when its expression from the nmt1 promoter was repressed by the addition of thiamine (Fig. 2B).
|
Expression of the hmg1-1 mutant gene bearing TGG to TGA nonsense mutation
In addition to the chromosome-borne Hmg1-GFP, the hmg1-1 mutant gene tagged with GFP was also subcloned into pREP1 vector and expressed under the control of the nmt1 promoter. When the gene expression was attenuated by the addition of thiamine to the medium, the suppression of the temperature sensitive phenotype of hmg1-1 mutant by the mutant gene was significant although weaker as compared with the strong suppression by the wild-type gene (Fig. 2A, +thiamine at 36 °C). In contrast, when it was overexpressed in the absence of thiamine, the growth defect was more severe than that observed with the wild-type gene (Fig. 2A, –thiamine at 27 °C). To our surprise, the localization of both the mutant Hmg1 protein tagged with GFP and the wild-type protein was identical (Fig. 2B). Then we analyzed the mutant Hmg1 protein expressed in wild-type cells by immunoblotting (Fig. 2E). The mutant Hmg1 protein tagged with GFP was found to be the same size as that of the wild-type protein. The amount of the mutant protein was lower (approximately 30%–50%) than that of the wild-type protein in both the attenuated and induced conditions.
Filipin staining of the hmg1-1 mutant cells
We next examined the cell morphology and the localization of the sterol using the fluorescent probe filipin, a polyene antibiotic that forms specific complexes with free 3-β-hydroxysterols. In the wild-type cells (Fig. 3A left panel), the filipin fluorescence was enriched in the plasma membrane at the growing cell tips and at the site of cytokinesis similar to that reported by Wachtler et al. (2003). In the hmg1-1 mutant (Fig. 3A right panel), the cells were slightly larger than the wild-type cells, however, their filipin fluorescence pattern was indistinguishable from that obtained with the wild-type cells at the permissive temperature of 27 °C. When the hmg1-1 mutant cells were shifted to the restrictive temperature of 36 °C for 4 h, a significant portion of the cells showed weaker filipin fluorescence suggesting decreased ergosterol levels in the mutant cells (Fig. 3B, right panel), whereas wild-type cells remained essentially unchanged in their staining pattern (Fig. 3B, left panel).
|
As reported in our previous studies, in wild-type cells cultured at 27 °C in the absence of FK506, the septation index was < 15% and increased to 27% at 6 h after the addition of FK506 (Zhang et al. 2000). In hmg1-1 mutant cells cultured at 27 °C in the absence of FK506, the septation index was 16%–20% which was only slightly higher than that of the wild-type cells (Fig. 4A) and remained unchanged upon temperature upshift (data not shown). Upon the addition of FK506, however, the hmg1-1 mutant cells showed a dramatic morphological change as compared with the wild-type cells and the septation index reached nearly 100% 6 h after the addition of FK506 (Fig. 4B). Also, it was noted that FK506-treated hmg1-1 mutant cells showed a markedly inhibited growth (Fig. 1A).
|
The hmg1+ gene is involved in cell wall integrity
Upon examination of the phenotypes of hmg1-1 mutant, it was observed that its temperature sensitivity was osmoremedial, that is, the mutant cells were capable of forming colonies at 36 °C on rich YPD plates containing 1.2 M sorbitol (Fig. 5A), suggesting a defect in cell wall integrity in hmg1-1 mutant. Then β-glucanase treatments on the hmg1-1 mutant, wild-type and
pmk1 cells were performed (Toda et al. 1996). Results showed that the hmg1-1 mutant cells lysed faster than wild-type cells, although the sensitivity of hmg1-1 mutant cells to β-glucanase was not as severe as that of the
pmk1 cells (Fig. 5B), which lack a MAP kinase regulating the cell wall integrity of fission yeast (Toda et al. 1996). These results suggest that hmg1-1 mutant cells are defective in cell wall integrity.
|
pck1 or
pck2, the deletion mutants of protein kinase C. These protein kinase C homologues are targets of Rho GTPases and differentially regulate cell integrity in fission yeast (Arellano et al. 1999). As shown in Fig. 5C, the hmg1-1
pck1 or hmg1-1
pck2 double mutants were more sensitive to high temperature than the hmg1-1 single mutants. The
pck2 mutant displayed more severe synthetic growth defects as compared with that of the
pck1 mutant. Identification of multicopy suppressors of the hmg1-1 mutant
To gain further insights into the mechanisms underlying the cause for the phenotypes observed in the hmg1-1 mutant, we screened for multicopy suppressors of the temperature sensitivity of the mutant. The hmg1-1 mutant was transformed with the multicopy genomic library as described for the cloning of the mutated gene. Approximately 30 000 transformants were obtained and replica-plated onto YPD and EMM plates. When the mutated gene in the hmg1-1 mutant was cloned by complementation of the temperature-sensitive growth, results showed that cells that grew at 36 °C were those cells with plasmids containing the hmg1+ gene. Then, the cells with plasmids that grew on EMM at 34 °C but not at 36 °C were isolated and studied further.
We isolated four genes as multicopy suppressors namely, erg12+, spo9+, pck1+, and an open reading frame with the systematic identification SPBC15C4.03, respectively (Fig. 6A). First, the erg12+ gene encodes mevalonate kinase that is located one step downstream from HMGR in the sterol biosynthesis pathway and catalyzes the ATP-dependent phosphorylation of mevalonic acid to form mevalonate 5-phosphate. Second, the spo9+ gene encodes geranylgeranyl pyrophosphate synthase (Ye et al. 2007) that is also located downstream of Hmg1 and Erg12. Third, the pck1+ gene encodes a homologue of protein kinase C that is regulated by Rho GTPases as described above. Pck1 suppressed the FK506-sensitive phenotype more efficiently than the other suppressors. Finally, SPBC15C4.03 encodes a homologue of Rab escort protein. It significantly suppressed the temperature-sensitive phenotype of the hmg1-1 mutant on YPD plate. We named the gene rep1+ for Rab escort protein.
|
The hmg1-1 mutant cells showed normal subcellular localization of small GTPases
In our previous published article, we showed that Rho2 is a target of the farnesyltransferase Cpp1 and cpp1 mutation or deletion resulted in the loss of plasma membrane-associated GFP-Rho2 (Ma et al. 2006). This prompted us to examine the localization of GFP-Rho2 and GFP-Ypt3 in hmg1-1 cells. The wild-type and hmg1-1 mutant cells expressing GFP-tagged small GTPases were incubated at 36 °C for 4 h, fixed by 0.1% formalin, and were observed under fluorescent microscope. In the hmg1-1 mutant cells, GFP-Rho2 localized at the plasma membrane and GFP-Ypt3 localized at the cell tips and at the intracellular dot-like structures in the same pattern as that in wild-type cells (Fig. 6C). These results suggest that reduced prenylation in hmg1-1 mutant alone is not sufficient to cause the mutant phenotypes.
Effects of pravastatin on the Schizosaccharomyces pombe mutants that showed genetic interaction with the hmg1-1 mutant
As described above, the hmg1-1 mutant showed synthetic growth defects with the mutant alleles of five genes that encode Cdc7, Cdc11, Pck1, Pck2 and Ypt3, respectively. Then we examined the effects of pravastatin, a competitive inhibitor of HMGR, on these mutants. The calcineurin deletion,
ppb1, was also examined for its sensitivity to pravastatin. Among the five mutants tested, only the ypt3-i5 mutant cells exhibited drug sensitivity. The ypt3-i5 mutant failed to grow in the presence of 0.3 mg/mL of pravastatin, whereas cdc7-24, cdc11-136,
pck1,
pck2 or
ppb1 cells grew (Fig. 7A). It was noted that none of the mutants tested showed higher drug sensitivity than that of the hmg1-1 mutant.
|
Recently, Iwaki et al. reported that disruption mutants of sterol biosynthesis genes were deficient in ergosterol and were resistant to polyene drugs such as amphotericin B (AmB) (Iwaki et al. 2008). The polyene drugs bind ergosterol, creating pores and causing cell lysis. Therefore, the tolerance to these drugs reflects the ergosterol deficiency of the mutants. Then we compared the tolerance to these drugs between the hmg1-1 mutant and disruption mutants of sterol biosynthesis genes, namely erg31+, erg32+, erg5+ and sts1+. The erg31+ gene and the erg32+
gene with the systematic identification SPAC1687.16c and SPBC27B12.03c, respectively, encode C-5 sterol desaturase; the erg5+
gene encodes C-22 sterol desaturase Erg5; and the sts1+ gene encodes C-24 (28) sterol reductase Sts1 (Iwaki et al. 2008). All of them were responsible for catalyzing a sequence of reactions from zymosterol to ergosterol. As regards the effect of AmB (Fig. 7B), the hmg1-1 mutant was sensitive, whereas
erg31
erg32 (
erg31&32),
erg5 and
sts1 disruption mutants were resistant. Notably, the hmg1-1 mutant was slightly but significantly more resistant to AmB compared with the wild-type cells. These results are consistent with the data obtained with filipin staining of the mutant cells which was indistinguishable from that obtained with the wild-type cells at the permissive temperature of 27 °C (Fig. 3A). Taken together, these observations suggest that ergosterol synthesis is attenuated, but its ergosterol level is not so affected in the hmg1-1 mutant as that of the disruption mutants of sterol biosynthesis genes. As regards the effect of high temperature and the effect of pravastatin (Fig. 7B), the hmg1-1 mutant was very sensitive while the disruption mutants were not sensitive. Iwaki et al. also reported that disruption mutants of sterol biosynthesis genes deficient in ergosterol were found to be hypersensitive to cycloheximide (Iwaki et al. 2008). As regards the effect of cycloheximide (CHX) (Fig. 7B), the ergosterol-deficient mutants especially
erg31
erg32 and
sts1 were hypersensitive to cycloheximide while the hmg1-1 mutant was not hypersensitive. As regards the effect of FK506 (Fig. 7B), however, all the ergosterol-deficient mutants were not hypersensitive to FK506 while the hmg1-1 mutant was hypersensitive. Taken together, drug-sensitivity characteristics between the hmg1-1 mutant and the disruption mutants of sterol biosynthesis genes were distinct suggesting that ergosterol deficiency alone is not sufficient to cause the mutant phenotypes of the hmg1-1 mutant.
| Discussion |
|---|
|
|
|---|
HMGR and small GTPases are highly conserved between yeasts and human, and yeast genetic approaches may prove useful in defining the cause of the pleiotropic effects of statins or in examining the effects of HMGR mutation. In budding yeast, however, a single deletion mutant of HMG1 or HMG2 has only a subtle growth defect other than growth on the medium containing the HMGR inhibitor compactin (Basson et al. 1986, 1987). Attempts to isolate temperature-sensitive lethal mutations in genes encoding enzymes of the sterol biosynthetic pathway also failed to identify mutations affecting HMGR activity (Servouse et al. 1984). In our study here, we showed that a mutation in the fission yeast hmg1+ gene caused temperature and FK506 sensitivity, and defects in cytokinesis and cell wall integrity. We compared the drug-sensitivity characteristics between the hmg1-1 mutant and the disruption mutants of sterol biosynthesis genes, and results suggest that these phenotypes are "pleiotropic", that is, the defects are not caused by ergosterol deficiency alone. Probably, these phenotypes are caused by the integrated effects of the reduced availability of ergosterol and various intermediates of the mevalonate pathway.
Previous study reported that the hmg1 null mutant is lethal (Lum et al. 1996). Here we demonstrated that the hmg1-1 allele contains an opal nonsense mutation at codon 234, which might result in a truncated protein lacking at the C-terminal three-fourths of the full-length product including a catalytic domain of Hmg1 that supplies the essential HMGR activity. So how is this mutant strain viable? When the mutated gene was expressed in wild-type cells (Fig. 2E), the immunoblot analysis detected a full-length protein with reduced amount but not a truncated protein. These results suggest that the viability of the hmg1-1 mutant might be the result of translational read-through, inasmuch as TGA is an infrequently (15%) used codon in S. pombe (Forsburg 1994). Consistent with this hypothesis, overexpression of tef1+ gene with the systematic identification SPAC23A1.10 encoding an elongation factor 1-
that is required during the elongation phase of translation suppressed the phenotypes of the hmg1-1 mutant (data not shown). Also in support of this hypothesis, overexpression of tRNA tryptophan encoded by the gene with the systematic identification SPATRNATRP.01 suppressed the phenotypes of the hmg1-1 mutant, as reported by Hsieh et al. (2004) that read-through of UGA stop codons by tRNATRP expressed (data not shown). Expression of the mutated gene did not fully suppress the mutant phenotype and was more toxic as compared with that of the wild-type gene. This suggests that the introduced termination codon may be mistranslated at some frequency. The proteins produced by the mistranslation might be nonfunctional and might also have the dominant negative effects on the cell growth as shown in Fig. 2A. The dominant negative nature of the mutation is consistent with the insufficient complementation of the hmg1-1 mutation by wild-type hmg1+ as shown in Fig. 1A. The mutation site of the hmg1-1 mutant, tryptophan at 234, is located in the transmembrane domain (Fig. 1B, lower panel). This site is also involved in the sterol-sensing domain where a homologue of Insig, Ins1, binds and regulates the phosphorylation of Hmg1 (Burg et al. 2008). Probably, Hmg1 phosphorylation might be reduced in the hmg1-1 mutant that contains an opal nonsense mutation at codon 234, thereby causing the dominant negative effects of the hmg1-1 mutant.
When the mutated gene tagged with GFP was expressed in wild-type cells, the amount of the mutant protein was lower (approximately 30%–50%) than the wild-type protein in both attenuated and induced conditions (Fig. 2C). Thus, it is suggested that lower ergosterol levels may be the direct cause of the mutant phenotypes observed. However, to our surprise, the hmg1-1 mutant was only slightly more resistant to AmB as compared with that of wild-type cells, suggesting that ergosterol level in the mutant is not very low as might be expected. This is in good agreement with the normal filipin staining pattern observed in the hmg1-1 mutant at 27 °C (Fig. 3A). In addition, the phenotype of the hmg1-1 mutant was not similar to that of any of the disruption mutants of sterol biosynthesis genes. Furthermore, hmg1-1 mutation showed synthetic growth defects with these disruption mutants (our unpublished observation). These results suggest that ergosterol deficiency alone is not sufficient to cause the mutant phenotypes. As described in the results, other researchers have shown that yeasts are more sensitive to FK506 and to inhibitors of sterol biosynthesis that act downstream of HMGR than to either drug alone (Onyewu et al. 2003). However, in the present study, we showed that
ppb1 (calcineurin deletion) was not hypersensitive to pravastatin. Although at present we do not know the relationship between sterol biosynthesis and calcineurin-mediated signal transduction, these results suggest that the HMGR inhibitor and the inhibitors of the enzymes that act downstream of HMGR in the ergosterol biosynthesis pathway have different effects on the physiology of yeast cells. These results also suggest that ergosterol deficiency is not the primary cause for the phenotypes of hmg1-1 mutant.
Then, we suggested that a defective isoprenoids biosynthesis in the hmg1-1 mutant cells may result in insufficient prenylation of Rho and Rab GTPases, which in turn affects cytokinesis and cell wall integrity because of the following observations: (i) the hmg1-1 mutant cells showed defects in cytokinesis and cell wall integrity that are regulated by Rho GTPases in fission yeast (Arellano et al. 1996; Garcia et al. 2006); (ii) genes encoding protein kinase C that are activated by Rho GTPases showed gene dosage-dependent suppression of the phenotype of hmg1-1 mutant; and (iii) overexpression of rep1+ that encodes Rab escort protein suppressed the phenotype of hmg1-1 mutant. In addition, Bialek-Wyrzykowska et al. reported the potential relationship between decreased prenylation as well as temperature sensitivity, and cell wall defects (Bialek-Wyrzykowska et al. 2000). To test whether the degree of prenylation in these small GTPases is affected by the mutation, we examined the localization of two small GTPases, Rho2 and Ypt3, in hmg1-1 mutant. As shown in Fig. 6C, the subcellular localization of GFP-tagged small GTPases appeared to be normal in hmg1-1 mutant cells, suggesting that reduced prenylation is not the primary cause for the phenotypes of hmg1-1 mutant, either.
In our previous study, we suggested that calcineurin is involved in the regulation of the septation initiation network pathway, and is required for the proper formation and maturation of the septum in fission yeast (Lu et al. 2002). Our present study showing the genetic interaction between calcineurin and HMGR suggest that HMGR is also involved in the regulation of cytokinesis.
In summary, our results suggest that an opal nonsense mutation caused the pleiotropic phenotypes of hmg1-1 mutant, and that ergosterol deficiency or reduced prenylation is not the primary cause for the pleiotropic defects. Probably, the defects reflect the integrated effects of the reduced availability of various intermediates of the mevalonate pathway. For example, the function of many membrane-bound or membrane associated proteins can be affected by changes in membrane fluidity or composition caused by decreased ergosterol production. Thus, rather than being a direct effect on prenylation alone, the observed phenotypes may reflect indirect effects on the function or activity of enzymes involved in prenylation.
| Experimental procedures |
|---|
|
|
|---|
Schizosaccharomyces pombe strains used in this study are listed in Table 1. The complete medium, YPD, and the minimal medium, EMM, have been described previously (Toda et al. 1996). Standard methods for S. pombe genetics were performed as described previously (Moreno et al. 1991). Gene disruptions are abbreviated by the gene preceded by
(for example,
pck1). Proteins are denoted by roman letters and only the first letter is capitalized (for example, Hmg1). FK506 and pravastatin were obtained from Astellas Pharma (Tokyo, Japan) and Daiichi Sankyo (Tokyo, Japan), respectively. All other chemicals and reagents were from commercial sources.
Gene expression
For ectopic expression of proteins, we used the thiamine-repressible nmt1 promoter (Basi et al. 1993; Maundrell 1993). Expression was repressed by the addition of 4 µg/mL thiamine to EMM and was induced by washing and incubating the cells in EMM lacking thiamine. To express Hmg1 tagged with green fluorescent protein (GFP), the genes from wild-type or hmg1-1 cells were tagged at their C terminus with GFP carrying S65T mutation. To obtain the chromosome-borne gene instead of the plasmid-borne gene, the gene with the nmt1 promoter was subcloned into the vector containing the ura4+ marker and was integrated into the chromosome at the ura4+ gene locus of KP1248 (Table 1). GFP-Rho2 and GFP-Ypt3 were expressed as described previously (He et al. 2006; Ma et al. 2006).
Bioinformatics
Database searches were performed using the National Center for Biotechnology Information BLAST network service (http://www.ncbi.nlm.nih.gov) and the Sanger Center S. pombe data base search service (http://www.sanger.ac.uk). Sequence alignment was performed using protein BLAST and the ClustalW program.
Microscopy and miscellaneous methods
Methods in light microscopy, such as fluorescence microscopy and differential interference contrast (DIC) microscopy, were performed as described (Cheng et al. 2002; Kita et al. 2004). Calcofluor and 4',6-diamidino-2-phenylindole (DAPI) were used to visualize cell wall and DNA, respectively as described previously (Cheng et al. 2002). For staining sterol, we used the fluorescent probe filipin, a polyene antibiotic that forms specific complexes with free 3-β-hydroxysterols (Drabikowski et al. 1973). Cells were grown to exponential phase in YPD medium at 27 °C, fixed in 2% formalin for 5 min, washed with phosphate buffered saline, and filipin was added to the medium and cells were observed immediately. Cell wall digestion by β-glucanase (Zymolyase, Seikagakukogyo, Tokyo, Japan) was performed as described (Toda et al. 1996).
| Acknowledgements |
|---|
| Footnotes |
|---|
These authors contributed equally to this article. | References |
|---|
|
|
|---|
Arellano, M., Duran, A. & Perez, P. (1996) Rho 1 GTPase activates the (1-3)β-D-glucan synthase and is involved in Schizosaccharomyces pombe morphogenesis. EMBO J. 15, 4584–4591.[Medline]
Arellano, M., Valdivieso, M.H., Calonge, T.M., Coll, P.M., Duran, A. & Perez, P. (1999) Schizosaccharomyces pombe protein kinase C homologues, pck1p and pck2p, are targets of rho1p and rho2p and differentially regulate cell integrity. J. Cell Sci. 112 (Pt 20), 3569–3578.[Abstract]
Basi, G., Schmid, E. & Maundrell, K. (1993) TATA box mutations in the Schizosaccharomyces pombe nmt1 promoter affect transcription efficiency but not the transcription start point or thiamine repressibility. Gene 123, 131–136.[CrossRef][Medline]
Basson, M.E., Thorsness, M. & Rine, J. (1986) Saccharomyces cerevisiae contains two functional genes encoding 3-hydroxy-3-methylglutaryl-coenzyme A reductase. Proc. Natl. Acad. Sci. USA 83, 5563–5567.
Basson, M.E., Moore, R.L., ORear, J. & Rine, J. (1987) Identifying mutations in duplicated functions in Saccharomyces cerevisiae: recessive mutations in HMG-CoA reductase genes. Genetics 117, 645–655.
Basson, M.E., Thorsness, M., Finer-Moore, J., Stroud, R.M. & Rine, J. (1988) Structural and functional conservation between yeast and human 3-hydroxy-3-methylglutaryl coenzyme A reductases, the rate-limiting enzyme of sterol biosynthesis. Mol. Cell. Biol. 8, 3797–3808.
Bialek-Wyrzykowska, U., Bauer, B.E., Wagner, W., Kohlwein, S.D., Schweyen, R.J. & Ragnini, A. (2000) Low levels of Ypt protein prenylation cause vesicle polarization defects and thermosensitive growth that can be suppressed by genes involved in cell wall maintenance. Mol. Microbiol. 35, 1295–1311.[CrossRef][Medline]
Burg, J.S., Powell, D.W., Chai, R., Hughes, A.L., Link, A.J. & Espenshade, P.J. (2008) Insig regulates HMG-CoA reductase by controlling enzyme phosphorylation in fission yeast. Cell Metab. 8, 522–531.[CrossRef][Medline]
Cheng, H., Sugiura, R., Wu, W., Fujita, M., Lu, Y., Sio, S.O., Kawai, R., Takegawa, K., Shuntoh, H. & Kuno, T. (2002) Role of the Rab GTP-binding protein Ypt3 in the fission yeast exocytic pathway and its connection to calcineurin function. Mol. Biol. Cell 13, 2963–2976.
Davidson, M.H. (2005) Clinical significance of statin pleiotropic effects: hypotheses versus evidence. Circulation 111, 2280–2281.
Deng, L., Sugiura, R., Ohta, K., Tada, K., Suziki, M., Hirata, M., Nakamura, S., Shuntoh, H. & Kuno, T. (2005) Phosphatidylinositol-4-phosphate 5-kinase regulates fission yeast cell integrity through a phospholipase C-mediated protein kinase C-independent pathway. J. Biol. Chem. 280, 27561–27568.
Drabikowski, W., Lagwinska, E. & Sarzala, M.G. (1973) Filipin as a fluorescent probe for the location of cholesterol in the membranes of fragmented sarcoplasmic reticulum. Biochim. Biophys. Acta 291, 61–70.[Medline]
Forsburg, S.L. (1994) Codon usage table for Schizosaccharomyces pombe. Yeast 10, 1045–1047.[CrossRef][Medline]
Futterman, L.G. & Lemberg, L. (2005) The expanding role of the HMG-CoA reductase inhibitor, the most widely prescribed drug in the world. Am. J. Crit. Care 14, 555–558.
Garcia, P., Tajadura, V., Garcia, I. & Sanchez, Y. (2006) Role of Rho GTPases and Rho-GEFs in the regulation of cell shape and integrity in fission yeast. Yeast 23, 1031–1043.[CrossRef][Medline]
Goldstein, J.L. & Brown, M.S. (1990) Regulation of the mevalonate pathway. Nature 343, 425–430.[CrossRef][Medline]
Hampton, R.Y. & Rine, J. (1994) Regulated degradation of HMG-CoA reductase, an integral membrane protein of the endoplasmic reticulum, in yeast. J. Cell Biol. 125, 299–312.
He, Y., Sugiura, R., Ma, Y., Kita, A., Deng, L., Takegawa, K., Matsuoka, K., Shuntoh, H. & Kuno, T. (2006) Genetic and functional interaction between Ryh1 and Ypt3: two Rab GTPases that function in S. pombe secretory pathway. Genes Cells 11, 207–221.
Hsieh, E.J., Dinoso, J.B. & Clarke, C.F. (2004) A tRNA(TRP) gene mediates the suppression of cbs2-223 previously attributed to ABC1/COQ8. Biochem. Biophys. Res. Commun. 317, 648–653.[CrossRef][Medline]
Hughes, A.L., Todd, B.L. & Espenshade, P.J. (2005) SREBP pathway responds to sterols and functions as an oxygen sensor in fission yeast. Cell 120, 831–842.[CrossRef][Medline]
Iwaki, T., Iefuji, H., Hiraga, Y., Hosomi, A., Morita, T., Giga-Hama, Y. & Takegawa, K. (2008) Multiple functions of ergosterol in the fission yeast Schizosaccharomyces pombe. Microbiology 154, 830–841.
Kita, A., Sugiura, R., Shoji, H., He, Y., Deng, L., Lu, Y., Sio, S.O., Takegawa, K., Sakaue, M., Shuntoh, H. & Kuno, T. (2004) Loss of Apm1, the µ1 subunit of the clathrin-associated adaptor-protein-1 complex, causes distinct phenotypes and synthetic lethality with calcineurin deletion in fission yeast. Mol. Biol. Cell 15, 2920–2931.
Koning, A.J., Larson, L.L., Cadera, E.J., Parrish, M.L. & Wright, R.L. (2002) Mutations that affect vacuole biogenesis inhibit proliferation of the endoplasmic reticulum in Saccharomyces cerevisiae. Genetics 160, 1335–1352.
Krapp, A., Gulli, M.P. & Simanis, V. (2004) SIN and the art of splitting the fission yeast cell. Curr. Biol. 14, R722–R730.[CrossRef][Medline]
Li, D., Singh, R.M., Liu, L., Chen, H., Singh, B.M., Kazzaz, N. & Mehta, J.L. (2003) Oxidized-LDL through LOX-1 increases the expression of angiotensin converting enzyme in human coronary artery endothelial cells. Cardiovasc. Res. 57, 238–243.
Liao, J.K. & Laufs, U. (2005) Pleiotropic effects of statins. Annu. Rev. Pharmacol. Toxicol. 45, 89–118.[CrossRef][Medline]
Liscum, L., Finer-Moore, J., Stroud, R.M., Luskey, K.L., Brown, M.S. & Goldstein, J.L. (1985) Domain structure of 3-hydroxy-3-methylglutaryl coenzyme A reductase, a glycoprotein of the endoplasmic reticulum. J. Biol. Chem. 260, 522–530.
Lu, Y., Sugiura, R., Yada, T., Cheng, H., Sio, S.O., Shuntoh, H. & Kuno, T. (2002) Calcineurin is implicated in the regulation of the septation initiation network in fission yeast. Genes Cells 7, 1009–1019.[Abstract]
Lum, P.Y. & Wright, R. (1995) Degradation of HMG-CoA reductase-induced membranes in the fission yeast, Schizosaccharomyces pombe. J. Cell Biol. 131, 81–94.
Lum, P.Y., Edwards, S. & Wright, R. (1996) Molecular, functional and evolutionary characterization of the gene encoding HMG-CoA reductase in the fission yeast, Schizosaccharomyces pombe. Yeast 12, 1107–1124.[CrossRef][Medline]
Luskey, K.L. & Stevens, B. (1985) Human 3-hydroxy-3-methylglutaryl coenzyme A reductase. Conserved domains responsible for catalytic activity and sterol-regulated degradation. J. Biol. Chem. 260, 10271–10277.
Ma, Y., Kuno, T., Kita, A., Asayama, Y. & Sugiura, R. (2006) Rho2 is a target of the farnesyltransferase Cpp1 and acts upstream of Pmk1 mitogen-activated protein kinase signaling in fission yeast. Mol. Biol. Cell 17, 5028–5037.
Maundrell, K. (1993) Thiamine-repressible expression vectors pREP and pRIP for fission yeast. Gene 123, 127–130.[CrossRef][Medline]
Moreno, S., Klar, A. & Nurse, P. (1991) Molecular genetic analysis of fission yeast Schizosaccharomyces pombe. Methods Enzymol. 194, 795–823.[Medline]
Nakanishi, M., Goldstein, J.L. & Brown, M.S. (1988) Multivalent control of 3-hydroxy-3-methylglutaryl coenzyme A reductase. Mevalonate-derived product inhibits translation of mRNA and accelerates degradation of enzyme. J. Biol. Chem. 263, 8929–8937.
Onyewu, C., Blankenship, J.R., Del Poeta, M. & Heitman, J. (2003) Ergosterol biosynthesis inhibitors become fungicidal when combined with calcineurin inhibitors against Candida albicans, Candida glabrata, and Candida krusei. Antimicrob. Agents Chemother. 47, 956–964.
Rosenson, R.S. (2004) Current overview of statin-induced myopathy. Am. J. Med. 116, 408–416.[CrossRef][Medline]
Servouse, M., Mons, N., Baillargeat, J.L. & Karst, F. (1984) Isolation and characterization of yeast mutants blocked in mevalonic acid formation. Biochem. Biophys. Res. Commun. 123, 424–430.[CrossRef][Medline]
Shepherd, J., Cobbe, S.M., Ford, I., Isles, C.G., Lorimer, A.R., MacFarlane, P.W., McKillop, J.H. & Packard, C.J. (1995) Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N. Engl. J. Med. 333, 1301–1307.
Takai, Y., Sasaki, T. & Matozaki, T. (2001) Small GTP-binding proteins. Physiol Rev. 81, 153–208.
Toda, T., Dhut, S., Superti-Furga, G., Gotoh, Y., Nishida, E., Sugiura, R. & Kuno, T. (1996) The fission yeast pmk1+ gene encodes a novel mitogen-activated protein kinase homolog which regulates cell integrity and functions coordinately with the protein kinase C pathway. Mol. Cell. Biol. 16, 6752–6764.
Wachtler, V., Rajagopalan, S. & Balasubramanian, M.K. (2003) Sterol-rich plasma membrane domains in the fission yeast Schizosaccharomyces pombe. J. Cell Sci. 116, 867–874.
Wang, C.Y., Liu, P.Y. & Liao, J.K. (2008) Pleiotropic effects of statin therapy: molecular mechanisms and clinical results. Trends Mol. Med. 14, 37–44.[CrossRef][Medline]
Wright, R., Basson, M., DAri, L. & Rine, J. (1988) Increased amounts of HMG-CoA reductase induce "karmellae" : a proliferation of stacked membrane pairs surrounding the yeast nucleus. J. Cell Biol. 107, 101–114.
Ye, Y., Fujii, M., Hirata, A., Kawamukai, M., Shimoda, C. & Nakamura, T. (2007) Geranylgeranyl diphosphate synthase in fission yeast is a heteromer of farnesyl diphosphate synthase (FPS), Fps1, and an FPS-like protein, Spo9, essential for sporulation. Mol. Biol. Cell 18, 3568–3581.
Zhang, Y., Sugiura, R., Lu, Y., Asami, M., Maeda, T., Itoh, T., Takenawa, T., Shuntoh, H. & Kuno, T. (2000) Phosphatidylinositol 4-phosphate 5-kinase Its3 and calcineurin Ppb1 coordinately regulate cytokinesis in fission yeast. J. Biol. Chem. 275, 35600–35606.
Accepted: 24 March 2009
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | ADVANCED SEARCH | TABLE OF CONTENTS |